FORMA Therapeutics Raises $25.5 Million

FORMA Therapeutics, a Cambridge, Mass.-based small molecule drug developer with an initial focus on cancer, has raised $25.5 million in Series B funding. Lilly Ventures led the round, and was joined by return backers Novartis Option Fund and Bio*One Capital. The company previously raised $25 million.

North AmericaUSBriefs